ArticleAlcohol and alcoholism (Oxford, Oxfordshire)2025
Lab tests can be used to predict phosphatidylethanol-measured high-risk alcohol use among people with HIV: a proof-of-concept using machine learning.
Article in Alcohol and alcoholism (Oxford, Oxfordshire), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of under-reporting of alcohol use with HIV viral non-suppression and an all-cause mortality risk score among people with HIV on antiretroviral therapy.Journal of acquired immune deficiency syndromes (1999) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
backgroundUnhealthy alcohol use is prevalent among persons with HIV (PWH) and is associated with adverse outcomes, but is underestimated partly due to use of self-reported measures prone to underreporting. Phosphatidylethanol (PEth) is a direct measure of past month alcohol consumption but is costly. We assessed whether lab and health data representing alcohol-associated physiologic changes could be leveraged with machine learning to predict PEth-measured high-risk alcohol use among PWH.
methodsWe pooled baseline data from two studies among PWH in Uganda that measured PEth (N = 988), and classified PEth as no/low/moderate (PEth <200 ng/ml) or high-risk (PEth ≥200 ng/ml). We split the data into training (n = 790) and testing (n = 198) sets, imputing missing data separately for each. We conducted supervised learning with 29 predictors from lab (e.g. complete blood count, liver enzymes) and other health (e.g. age, sex, blood pressure) data using LASSO logistic regression, extreme gradient boosted decision trees, and random forests. We identified the optimal model via the largest area under the curve (AUC).
resultsA LASSO regression with 17 predictors was the optimal model (cross-validated AUC in the Training Set = 0.751, 95% confidence interval [CI]: 0.718-0.784; AUC in Testing Set = 0.795, 95% CI: 0.723-0.852).
conclusionsThis study suggests that a combination of lab and health data is useful for identifying individuals engaging in high-risk alcohol use (PEth ≥200 ng/ml). Algorithms including other indirect markers of alcohol use (e.g. gamma glutamyltransferase) may improve identification of high-risk alcohol use, which could be useful in research and clinical settings where PEth testing is unavailable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.